CCCC Clinical Study Guide Flashcards
What antibodies have been implicated in HDFN?
ABORh, Kell, Duffy (uncommon), Kidd, anti-S, anti-s, anti-U, anti-M (in IgG form; this is rare)
What antibodies have been implicated in HTR?
Kell, Duffy, Kidd, anti-S, anti-s, anti-U, rare form of anti-P1 reactive at 37 degrees
How can cold agglutinins be excluded from testing?
perform the antibody screen (and panel is necessary) using the prewarm technique
How can Rouleaux be excluded from testing?
perform the saline replacement technique
What antibodies does the immediate spin phase of tube testing detect?
M, N, P, ABORh, Ii
What phases other than immediate spin do anti-P and anti-I/i react at?
room temperature and 4 degrees Celsius
What antibodies does the 37 degree phase of tube testing detect?
M and N
What antibodies does the AHG phase of testing detect?
Kell, Duffy, Kidd, MN, Ss, and Lutheran (which can also react at room temperature)
How much time must pass between each donation of blood products?
whole blood, RBCs, WBCs - once every 8 weeks; platelets - no more than twice a week or 24 times a year, provided platelet count is at least 150,000/uL and at least 48 hrs. between donations; plasma - no more than twice every 7 days, with 48 hrs. between donations
What are the hemoglobin and hematocrit values acceptable for blood donation?
Hgb: >/= 12.5 g/dL, Hct: >/= 38%
What is the total volume of blood drawn in a single donation setting?
routine amount drawn is 450 mL +/- 10%; maximum bleed is 525 mL (including 2-4 tubes for testing)
What conditions would permanently defer someone from donating blood products?
use of intravenous drugs (even once); man who has had sex with another man since 1977 (even once); hemophilia; + antibody test for HIV; man or woman who has had sex for drugs or money since 1977; had viral hepatitis; cancer (except in situ basal cell carcinoma or in situ cervical cancer if successfully treated); multiple sclerosis; had coronary artery bypass surgery; had a stroke; history of babesiosis (Chagas disease); take or have taken Tegison for psoriasis; history of Creutzfeld-Jakob disease in donor or donor family members; clinical/laboratory evidence of human T-cell lymphotrophic virus (HTLV); recipient of dura mater or pituitary growth hormone; clotting or other blood disorder; sickle cell disease or other hemoglobinopathies; sexual contact with anyone who was born or lived in Africa; have been to Africa; used clotting factor concentrates; had malaria*; spent 5 or more years in Europe since 1980; received a blood transfusion in the UK or France since 1980
How much must a donor weigh?
> /= 110 lbs.
What special circumstances apply to deferrals related to malaria?
if donor has been asymptomatic after the diagnosis of malaria, the deferral time is 3 years
Give the probable genotype for the following Rh type: R(zero)
cDe
Give the probable genotype for the following Rh type: R1
CDe
Give the probable genotype for the following Rh type: R2
cDE
Give the probable genotype for the following Rh type: Rz
CDE
Give the probable genotype for the following Rh type: r
cde
Give the probable genotype for the following Rh type: r’
Cde
Give the probable genotype for the following Rh type: r”
cdE
Give the probable genotype for the following Rh type: ry
CdE
List the guidelines and blood selection for emergency transfusions and alternate blood selection.
- Always obtain a sample for crossmatching regardless of whether it can be done before units are sent out. 2. If there is time for a TNS, perform one and issue ABO compatible units; if there is no time, issue O= units, and switch to ABO compatible once the TNS has been performed. 3. All transfusion tickets MUST be stamped with “Compatibility Testing Not Completed” in red ink, and an emergency release form MUST be signed by the attending physician. 4. Perform the crossmatch ASAP, and notify the nurse or physician if: the crossmatch is complete and there are compatible units available; if an antibody has been detected; if the emergency release units were found to be incompatible with the patient. 5. In the event that emergency units are found to be incompatible, notify the medical director or the pathologist on call, and complete a blood product deviation form.
At what temperature do commonly encountered antibodies react?
37 degrees Celsius
What temperature should blood storage refrigerators be kept at?
2-8 degrees Celsius
How long are recipient samples kept in the lab?
10 days
What is the shelf life of blood after the hermetic seal has been broken?
4 hours if kept at room temperature, 24 hours if refrigerated
What temperature should whole blood be kept at during shipping?
1-10 degrees Celsius
What is the criteria for disposing of blood products?
considered regulated medical waste; should be contained in a red plastic disposable biohazard bag at least 1.5 mm thick and impervious to moisture, which are then sealed in biohazard boxes before being picked up and incinerated
What is the order of reactivity of all of the ABO blood groups with anti-H?
O > A2 > B > A2B > A1 > A1B
What is whole blood requested for?
used for patients who are actively bleeding and have lost more than 25% of their blood volume (acute blood loss), or for patients undergoing and exchange transfusion
What are the storage conditions and shelf life of whole blood?
should be stored at 1-6*C; 21 days in CPD and CP2D, 35 days in CPDA-1.
How does irradiation affect the shelf life of blood?
expires 28 days from the date of irradiation, or on the original expiration date - whichever comes first
What are packed RBCs requested for?
Increases the mass of circulating RBCs in situations where tissue oxygenation may be impaired by acute or chronic blood loss. Conditions include: oncology patients undergoing chemotherapy or radiation; trauma victims; patients undergoing cardiac, orthopedic, or other surgery; patients with end-stage renal disease; premature infants; sickle cell patients; and other causes of anemia or hemorrhage.
What are the storage conditions and shelf life of packed RBCs?
same as whole blood, with the additional condition of 45 days if they are stored in AS-1, AS-3, or AS-5
What is Rejuvenation Solution and when is it used?
Composed of pyruvate, inosine, phosphate, and adenine. It is not routinely used, but may be necessary to restore 2,3-DPG and ATP levels in RBC units collected in CPD or CPDA-1 during storage or up to 3 days after the expiration date. It can also extend the expiration date for freezing or transfusing an RBC unit, which may be necessary when rare or autologous units are involved. Washing to remove the inosine before use is REQUIRED, as it may be toxic to the recipient.
Define Frozen Deglycerolized RBCs, including their shelf life and storage conditions.
RBCs are sometimes frozen in glycerol as a means of long-term preservation for rare and autologous units. These units are free of leukocytes, platelets, and plasma. They can be stored for up to 10 years at or below -65*C. However, because the thawing process involves entering the blood unit, it is considered “open” at that point and must be transfused within 24 hours of thawing.
When would saline-washed RBCs be requested and why?
Washing removes the small amount of plasma proteins that remain in RBC units, which some patients may react to. IgA-deficient patients with clinically significant anti-IgA require washed RBCs if a transfusion is necessary. They may also be requested for infants or intrauterine transfusions.
When would irradiated RBCs (or other blood products) be requested?
Irradiation is required when the selected blood unit is from a blood relative of the recipient, or if the donor unit is HLA-matched for the recipient. It is also suggested for patients receiving intrauterine transfusion; suffering from iimmunoincompetence or immunodeficiency; have received allogeneic marrow or peripheral blood progenitor cells; are a premature newborn; or are undergoing extensive chemotherapy and/or radiation.
When would fresh frozen plasma (FFP) be requested?
used for management of bleeding patients that require factors II, V, VII, X, or XI when concentrates are not available or appropriate; abnormal coag. assays resulting from massive transfusion; patients anticoagulated with warfarin who are bleeding or require emergency surgery; replacement solution for therapeutic plasmapheresis patients treated for thrombotic thrombocytopenic purpura (TTP) or hemolytic uremic syndrome; correction or prevention of bleeding complications in patients with severe liver disease with multiple factor deficiencies; patients with deficiencies in the inhibitor antithrombin III who are undergoing surgery; cases of Disseminated Intravascular Coagulation (DIC) when fibrinogen levels are below 100 mg/dL